Literature DB >> 16648143

Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis.

J H Veldink1, S Kalmijn, G-J Groeneveld, W Wunderink, A Koster, J H M de Vries, J van der Luyt, J H J Wokke, L H Van den Berg.   

Abstract

BACKGROUND: To assess whether the premorbid dietary intake of fatty acids, cholesterol, glutamate or antioxidants was associated with the risk of developing amyotrophic lateral sclerosis (ALS).
METHODS: Patients referred to our clinic during 2001-2002, who had definite, probable or possible ALS according to El Escorial criteria, without a familial history of ALS, were asked to participate in a case-control study (132 patients and 220 healthy controls). A food-frequency questionnaire was used to assess dietary intake for the nutrients of interest. Multivariate logistic regression analysis was performed with adjustment for confounding factors (sex, age, level of education, energy intake, body mass index and smoking).
RESULTS: A high intake of polyunsaturated fatty acid (PUFA) and vitamin E was significantly associated with a reduced risk of developing ALS (PUFA: odds ratio (OR) = 0.4, 95% confidence interval (CI) = 0.2 to 0.7, p = 0.001; vitamin E: OR = 0.4, 95% CI = 0.2 to 0.7, p = 0.001). PUFA and vitamin E appeared to act synergistically, because in a combined analysis the trend OR for vitamin E was further reduced from 0.67 to 0.37 (p = 0.02), and that for PUFA from 0.60 to 0.26 (p = 0.005), with a significant interaction term (p = 0.03). The intake of flavonols, lycopene, vitamin C, vitamin B2, glutamate, calcium or phytoestrogens was not associated with the risk of developing ALS.
CONCLUSION: A high intake of PUFAs and vitamin E is associated with a 50-60% decreased risk of developing ALS, and these nutrients appear to act synergistically.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648143      PMCID: PMC2077791          DOI: 10.1136/jnnp.2005.083378

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  35 in total

Review 1.  Omega 3 fatty acids and cardiovascular disease--fishing for a natural treatment.

Authors:  Jehangir N Din; David E Newby; Andrew D Flapan
Journal:  BMJ       Date:  2004-01-03

2.  Antecedent events in amyotrophic lateral sclerosis.

Authors:  M T Felmus; B M Patten; L Swanke
Journal:  Neurology       Date:  1976-02       Impact factor: 9.910

3.  Polyunsaturated fatty acids are potent neuroprotectors.

Authors:  I Lauritzen; N Blondeau; C Heurteaux; C Widmann; G Romey; M Lazdunski
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

Review 4.  Umami and food palatability.

Authors:  S Yamaguchi; K Ninomiya
Journal:  J Nutr       Date:  2000-04       Impact factor: 4.798

5.  Repeat study of antecedent events in motor neuron disease.

Authors:  R Pierce-Ruhland; B M Patten
Journal:  Ann Clin Res       Date:  1981-04

6.  Marked increase in cyclooxygenase-2 in ALS spinal cord: implications for therapy.

Authors:  K Yasojima; W W Tourtellotte; E G McGeer; P L McGeer
Journal:  Neurology       Date:  2001-09-25       Impact factor: 9.910

Review 7.  An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis.

Authors:  Carmel Armon
Journal:  Neuroepidemiology       Date:  2003 Jul-Aug       Impact factor: 3.282

8.  VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death.

Authors:  Diether Lambrechts; Erik Storkebaum; Masafumi Morimoto; Jurgen Del-Favero; Frederik Desmet; Stefan L Marklund; Sabine Wyns; Vincent Thijs; Jörgen Andersson; Ingrid van Marion; Ammar Al-Chalabi; Stephanie Bornes; Rhiannon Musson; Valerie Hansen; Lars Beckman; Rolf Adolfsson; Hardev Singh Pall; Hervé Prats; Severine Vermeire; Paul Rutgeerts; Shigehiro Katayama; Takuya Awata; Nigel Leigh; Loïc Lang-Lazdunski; Mieke Dewerchin; Christopher Shaw; Lieve Moons; Robert Vlietinck; Karen E Morrison; Wim Robberecht; Christine Van Broeckhoven; Désiré Collen; Peter M Andersen; Peter Carmeliet
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

9.  Dietary intake of antioxidants and risk of Alzheimer disease.

Authors:  Marianne J Engelhart; Mirjam I Geerlings; Annemieke Ruitenberg; John C van Swieten; Albert Hofman; Jacqueline C M Witteman; Monique M B Breteler
Journal:  JAMA       Date:  2002-06-26       Impact factor: 56.272

Review 10.  Sporadic lower motor neuron disease with adult onset: classification of subtypes.

Authors:  R M van den Berg-Vos; J Visser; H Franssen; M de Visser; J M B V de Jong; S Kalmijn; J H J Wokke; L H van den Berg
Journal:  Brain       Date:  2003-05       Impact factor: 13.501

View more
  34 in total

1.  Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials.

Authors:  Albert C Ludolph; Sarah Jesse
Journal:  Ther Adv Neurol Disord       Date:  2009-09       Impact factor: 6.570

2.  Dietary ω-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis.

Authors:  Kathryn C Fitzgerald; Éilis J O'Reilly; Guido J Falcone; Marjorie L McCullough; Yikyung Park; Laurence N Kolonel; Alberto Ascherio
Journal:  JAMA Neurol       Date:  2014-09       Impact factor: 18.302

3.  Pre-diagnostic plasma urate and the risk of amyotrophic lateral sclerosis.

Authors:  Éilis J O'Reilly; Kjetil Bjornevik; Michael A Schwarzschild; Marjorie L McCullough; Laurence N Kolonel; Loic Le Marchand; Joann E Manson; Alberto Ascherio
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-12-26       Impact factor: 4.092

4.  Dietary lipid unsaturation influences survival and oxidative modifications of an amyotrophic lateral sclerosis model in a gender-specific manner.

Authors:  Daniel Cacabelos; Victoria Ayala; Omar Ramírez-Nunez; Ana Belen Granado-Serrano; Jordi Boada; Jose C E Serrano; Rosanna Cabré; Gisela Nadal-Rey; Maria Josep Bellmunt; Isidro Ferrer; Reinald Pamplona; Manuel Portero-Otin
Journal:  Neuromolecular Med       Date:  2014-07-01       Impact factor: 3.843

Review 5.  Nutrition and dietary supplements in motor neuron disease.

Authors:  Jeffrey Rosenfeld; Amy Ellis
Journal:  Phys Med Rehabil Clin N Am       Date:  2008-08       Impact factor: 1.784

6.  Dietary supplementation with S-adenosyl methionine delays the onset of motor neuron pathology in a murine model of amyotrophic lateral sclerosis.

Authors:  James Suchy; Sangmook Lee; Ambar Ahmed; Thomas B Shea
Journal:  Neuromolecular Med       Date:  2009-09-16       Impact factor: 3.843

7.  The role of dietary antioxidant insufficiency on the permeability of the blood-brain barrier.

Authors:  Hussni O Mohammed; Simon R Starkey; Korona Stipetic; Thomas J Divers; Brian A Summers; Alexander de Lahunta
Journal:  J Neuropathol Exp Neurol       Date:  2008-12       Impact factor: 3.685

8.  Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: pooled results from 5 cohort studies.

Authors:  Kathryn C Fitzgerald; Éilis J O'Reilly; Elinor Fondell; Guido J Falcone; Marjorie L McCullough; Yikyung Park; Laurence N Kolonel; Alberto Ascherio
Journal:  Ann Neurol       Date:  2013-01-29       Impact factor: 10.422

9.  Current and emerging treatments for amyotrophic lateral sclerosis.

Authors:  Stefano Zoccolella; Andrea Santamato; Paolo Lamberti
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-16       Impact factor: 2.570

10.  A common haplotype within the PON1 promoter region is associated with sporadic ALS.

Authors:  John E Landers; Lijia Shi; Ting-Jan Cho; Jonathan D Glass; Christopher E Shaw; P Nigel Leigh; Frank Diekstra; Meraida Polak; Ildefonso Rodriguez-Leyva; Stephan Niemann; Bryan J Traynor; Diane McKenna-Yasek; Peter C Sapp; Ammar Al-Chalabi; Anne-Marie A Wills; Robert H Brown
Journal:  Amyotroph Lateral Scler       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.